P49184
Gene name |
DNASE1L1 (DNAS1L1, DNL1L) |
Protein name |
Deoxyribonuclease-1-like 1 |
Names |
DNase X, Deoxyribonuclease I-like 1, DNase I-like 1, Muscle-specific DNase I-like, XIB |
Species |
Homo sapiens (Human) |
KEGG Pathway |
hsa:1774 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for P49184
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-P49184-F1 | Predicted | AlphaFoldDB |
170 variants for P49184
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
|
CA337283822 rs1035422822 |
4 | P>S | No |
ClinGen Ensembl |
|
|
rs141794041 CA10562220 |
5 | T>I | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
rs141794041 CA10562221 |
5 | T>S | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
CA415175068 rs1557188274 |
14 | N>D | No |
ClinGen gnomAD |
|
|
rs138580997 CA10562218 |
14 | N>S | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
rs782184791 CA10562216 |
16 | A>V | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA TOPMed gnomAD |
|
CA337283813 COSM2151276 rs1011162917 |
20 | R>C | Variant assessed as Somatic; 0.0 impact. central_nervous_system [NCI-TCGA, Cosmic] | No |
ClinGen cosmic curated NCI-TCGA TOPMed gnomAD |
|
CA10562215 rs781926586 |
20 | R>H | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs782219897 CA10562213 |
23 | A>T | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs1557188246 CA415174805 |
23 | A>V | No |
ClinGen gnomAD |
|
|
CA10562212 rs782656826 |
25 | N>S | No |
ClinGen ExAC gnomAD |
|
|
rs781973534 CA10562210 |
28 | R>W | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
|
CA337283780 rs140776268 |
30 | T>S | No |
ClinGen ESP TOPMed |
|
|
CA337283776 rs200634352 |
31 | L>V | No |
ClinGen gnomAD |
|
|
rs144878211 CA10562208 |
32 | A>T | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
| TCGA novel | 32 | A>V | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
CA10562207 rs781836649 |
36 | R>G | No |
ClinGen ExAC gnomAD |
|
|
CA10562206 rs782742803 |
38 | Q>E | No |
ClinGen ExAC gnomAD |
|
|
CA10562204 rs781851548 |
41 | D>E | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA415174275 rs1557188201 |
41 | D>N | No |
ClinGen gnomAD |
|
|
rs782809884 CA10562203 |
44 | V>A | No |
ClinGen ExAC TOPMed gnomAD |
|
| TCGA novel | 44 | V>D | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
CA10562202 rs782142885 |
45 | R>G | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA10562201 rs781926646 |
45 | R>Q | No |
ClinGen ExAC gnomAD |
|
|
rs782142885 CA415174128 |
45 | R>W | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA TOPMed gnomAD |
|
CA415264508 rs1557188082 |
46 | I>M | No |
ClinGen gnomAD |
|
|
CA415264499 rs1324433603 |
48 | A>V | No |
ClinGen TOPMed |
|
|
rs1557188075 CA415264494 |
49 | R>C | No |
ClinGen gnomAD |
|
|
rs781844808 CA10562184 |
49 | R>H | No |
ClinGen ExAC gnomAD |
|
|
rs781844808 CA10562183 |
49 | R>P | No |
ClinGen ExAC gnomAD |
|
|
rs1197929465 CA415264489 |
50 | C>Y | No |
ClinGen TOPMed |
|
|
CA10562182 rs782750958 |
51 | D>G | No |
ClinGen ExAC gnomAD |
|
|
CA415264483 rs1557188065 |
51 | D>N | No |
ClinGen gnomAD |
|
|
CA10562180 rs781860537 |
52 | I>V | No |
ClinGen ExAC gnomAD |
|
|
rs1236324527 CA415264467 |
53 | M>T | No |
ClinGen TOPMed |
|
|
CA415264453 rs1177590324 |
55 | L>V | No |
ClinGen TOPMed |
|
|
CA415264428 rs1557188044 |
58 | V>G | No |
ClinGen gnomAD |
|
|
CA415264418 rs1603372341 |
60 | D>A | No |
ClinGen Ensembl |
|
| TCGA novel | 63 | G>C | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs781998671 CA10562174 |
63 | G>D | No |
ClinGen ExAC gnomAD |
|
|
rs1557188029 CA415264399 |
63 | G>S | No |
ClinGen gnomAD |
|
| TCGA novel | 64 | S>G | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs782288295 CA10562172 |
65 | A>T | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA TOPMed gnomAD |
|
rs1557188017 CA415264378 |
66 | I>T | No |
ClinGen gnomAD |
|
|
rs200058172 CA10562170 |
67 | P>L | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
|
rs200058172 CA337300200 |
67 | P>R | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
|
rs782069083 CA10562171 |
67 | P>S | No |
ClinGen 1000Genomes ExAC gnomAD |
|
|
rs781912078 CA337300173 |
71 | R>* | Variant assessed as Somatic; impact. [NCI-TCGA] | No |
ClinGen NCI-TCGA gnomAD |
|
rs781912078 CA415264356 |
71 | R>G | No |
ClinGen gnomAD |
|
|
CA10562166 rs141797285 |
71 | R>Q | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ESP ExAC NCI-TCGA TOPMed gnomAD |
| TCGA novel | 72 | E>* | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs782632206 CA10562165 |
74 | N>S | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs147897069 CA10562164 |
75 | R>Q | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
CA10562155 rs377310204 |
80 | G>E | No |
ClinGen ESP ExAC gnomAD |
|
|
rs959981012 CA337300092 |
81 | P>H | No |
ClinGen Ensembl |
|
|
rs782223297 CA10562152 |
87 | S>R | No |
ClinGen ExAC gnomAD |
|
|
CA415264216 rs1557187966 |
90 | L>R | No |
ClinGen gnomAD |
|
|
CA10562151 rs782657741 |
92 | R>C | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs782580939 CA337300091 |
92 | R>H | Variant assessed as Somatic; impact. [NCI-TCGA] | No |
ClinGen NCI-TCGA TOPMed gnomAD |
|
CA10562148 rs782676794 |
95 | Y>C | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs782676794 CA415264188 |
95 | Y>F | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA10562149 rs782676794 |
95 | Y>S | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA415264185 rs1557187958 |
96 | M>L | No |
ClinGen gnomAD |
|
|
CA10562147 rs144754107 |
98 | T>M | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
|
CA415264129 rs1190917095 |
103 | Y>C | No |
ClinGen TOPMed |
|
|
CA10562143 rs781858230 |
104 | R>Q | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs782518355 CA10562144 |
104 | R>W | No |
ClinGen ExAC gnomAD |
|
|
rs144202041 CA10562124 |
109 | Q>E | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
rs782579104 CA10562123 |
109 | Q>H | No |
ClinGen ExAC gnomAD |
|
|
CA415264080 rs1267791238 |
109 | Q>R | No |
ClinGen TOPMed |
|
|
rs1557187659 CA415264071 |
110 | V>G | No |
ClinGen gnomAD |
|
|
CA415264047 rs1557187651 |
114 | Y>C | No |
ClinGen gnomAD |
|
|
rs376865907 CA10562119 |
115 | V>M | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
CA415264031 rs1557187643 |
116 | Y>* | No |
ClinGen gnomAD |
|
|
CA415264030 rs1557187642 |
117 | N>D | No |
ClinGen gnomAD |
|
|
rs1569552407 CA415264015 |
118 | D>E | No |
ClinGen Ensembl |
|
|
CA415264021 rs1170447353 |
118 | D>H | No |
ClinGen TOPMed |
|
|
rs781863598 CA10562117 |
119 | E>K | No |
ClinGen ExAC gnomAD |
|
|
VAR_048869 CA10562114 rs34952165 |
122 | V>I | No |
ClinGen UniProt 1000Genomes ESP ExAC TOPMed dbSNP gnomAD |
|
| TCGA novel | 124 | A>V | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs782095435 CA415263972 |
125 | R>G | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs782095435 CA10562112 |
125 | R>W | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs781956733 CA10562111 |
130 | A>V | No |
ClinGen ExAC gnomAD |
|
|
CA10562110 rs782367096 |
134 | L>S | No |
ClinGen ExAC gnomAD |
|
|
CA415263715 rs1557187531 |
143 | V>L | No |
ClinGen gnomAD |
|
|
rs1557187520 CA415263684 |
146 | P>L | No |
ClinGen gnomAD |
|
|
CA415263664 rs1557187508 |
149 | T>A | No |
ClinGen gnomAD |
|
|
rs372745600 CA10562080 |
154 | V>I | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ESP ExAC NCI-TCGA TOPMed gnomAD |
|
CA10562079 rs782688838 |
155 | E>K | No |
ClinGen ExAC gnomAD |
|
|
COSM3379439 rs781802964 CA10562077 |
160 | A>T | pancreas [Cosmic] | No |
ClinGen cosmic curated ExAC TOPMed gnomAD |
|
rs368820912 CA10562076 |
162 | Y>* | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
rs1557187476 CA415263554 |
162 | Y>H | No |
ClinGen gnomAD |
|
|
rs781814446 CA10562074 |
163 | D>N | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA TOPMed gnomAD |
|
rs782112395 CA10562072 |
167 | E>G | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA10562073 rs782775845 |
167 | E>K | No |
ClinGen ExAC gnomAD |
|
|
CA415263513 rs782775845 |
167 | E>Q | No |
ClinGen ExAC gnomAD |
|
|
CA10562071 rs6643670 CA337298915 |
170 | Q>H | No |
ClinGen ExAC gnomAD |
|
|
CA415263484 rs1557187459 |
170 | Q>R | No |
ClinGen gnomAD |
|
|
CA10562052 rs781811156 |
176 | D>N | No |
ClinGen ExAC gnomAD |
|
|
CA415263392 rs1557187410 |
178 | I>T | No |
ClinGen gnomAD |
|
|
rs782099734 CA10562050 |
180 | L>F | No |
ClinGen ExAC |
|
|
CA10562049 rs781950844 |
186 | D>N | No |
ClinGen ExAC gnomAD |
|
|
CA10562048 rs782781213 |
187 | C>G | No |
ClinGen ExAC gnomAD |
|
|
rs782325226 CA10562045 |
188 | A>G | No |
ClinGen ExAC gnomAD |
|
|
rs782017649 CA10562046 |
188 | A>T | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA TOPMed gnomAD |
|
rs1460218830 CA415263311 |
191 | T>N | No |
ClinGen TOPMed gnomAD |
|
|
rs782174612 CA10562044 |
194 | R>C | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA10562043 rs199865662 |
194 | R>H | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA gnomAD |
|
CA10562042 rs782332152 |
198 | L>P | No |
ClinGen ExAC gnomAD |
|
|
CA10562041 rs367625596 |
199 | E>D | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
CA415263262 rs1557187356 |
199 | E>Q | No |
ClinGen gnomAD |
|
|
CA415263247 rs1469827058 |
201 | R>Q | Variant assessed as Somatic; impact. [NCI-TCGA] | No |
ClinGen NCI-TCGA TOPMed |
|
rs1557187347 CA415263243 |
202 | T>N | No |
ClinGen gnomAD |
|
| TCGA novel | 203 | E>K | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs1557187336 CA415263227 |
204 | P>L | No |
ClinGen gnomAD |
|
|
rs1175773755 CA415263232 |
204 | P>T | No |
ClinGen TOPMed gnomAD |
|
|
CA415263191 rs1410215561 |
209 | V>A | No |
ClinGen TOPMed gnomAD |
|
|
CA415263179 rs868947585 |
211 | A>V | No |
ClinGen Ensembl |
|
|
CA415263176 rs1457884365 |
212 | D>N | Variant assessed as Somatic; impact. [NCI-TCGA] | No |
ClinGen NCI-TCGA TOPMed |
|
rs1175562608 CA415263165 |
213 | G>E | No |
ClinGen TOPMed |
|
| TCGA novel | 214 | E>V | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
CA10562034 rs200843535 |
217 | T>I | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
|
CA10562032 rs781857571 |
219 | R>Q | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA10562033 rs782515836 |
219 | R>W | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA TOPMed gnomAD |
| TCGA novel | 221 | S>N | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
CA415263085 rs1557187304 |
225 | T>I | No |
ClinGen gnomAD |
|
|
rs5987256 CA337298688 |
227 | D>A | No |
ClinGen TOPMed |
|
|
rs5987256 CA415263073 |
227 | D>G | No |
ClinGen TOPMed |
|
|
rs782791446 CA10562031 |
228 | R>C | No |
ClinGen ExAC TOPMed |
|
|
CA415263067 rs1557187287 |
228 | R>H | Variant assessed as Somatic; impact. [NCI-TCGA] | No |
ClinGen NCI-TCGA gnomAD |
|
rs781790725 CA10562029 |
229 | V>I | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs782735749 CA415263059 |
230 | V>L | No |
ClinGen ExAC gnomAD |
|
|
rs782735749 CA10562028 |
230 | V>M | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA gnomAD |
|
CA10562027 rs782074804 |
232 | H>Y | No |
ClinGen ExAC gnomAD |
|
|
rs782374192 CA10562025 |
235 | R>C | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA TOPMed gnomAD |
|
CA10562024 rs782154480 |
235 | R>H | No |
ClinGen ExAC gnomAD |
|
|
rs782331239 CA10562022 |
237 | R>Q | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA TOPMed gnomAD |
|
CA10562023 rs782023962 |
237 | R>W | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA10562020 rs782626715 |
239 | L>P | No |
ClinGen ExAC gnomAD |
|
|
CA10562019 rs782340452 |
243 | A>P | No |
ClinGen ExAC gnomAD |
|
| TCGA novel | 244 | A>T | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
| TCGA novel | 250 | T>H | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs782157533 CA337298641 |
250 | T>M | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs782157533 CA10562016 |
250 | T>R | No |
ClinGen ExAC TOPMed gnomAD |
|
| TCGA novel | 252 | F>S | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs1198800756 CA415262816 |
256 | E>K | No |
ClinGen TOPMed gnomAD |
|
| TCGA novel | 257 | E>D | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
CA415262803 rs1557187214 |
257 | E>K | No |
ClinGen gnomAD |
|
|
CA10562013 rs782488318 |
258 | E>* | No |
ClinGen ExAC gnomAD |
|
|
CA10561995 rs781847383 |
262 | I>L | No |
ClinGen ExAC gnomAD |
|
|
CA10561994 rs782668660 |
263 | S>G | No |
ClinGen ExAC gnomAD |
|
|
rs782540310 CA10561993 |
263 | S>I | No |
ClinGen ExAC gnomAD |
|
|
rs782719035 CA10561991 |
270 | V>A | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA gnomAD |
|
CA415262560 rs1339087563 |
275 | S>G | No |
ClinGen TOPMed |
|
|
CA10561990 rs146004451 |
276 | Q>R | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
|
rs781833694 CA10561989 |
277 | A>V | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA TOPMed gnomAD |
|
rs1266861547 CA415262539 |
278 | H>Y | No |
ClinGen TOPMed |
|
|
CA10561986 rs148008384 |
280 | V>I | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
|
rs148008384 CA10561987 |
280 | V>L | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
|
rs1603370933 CA415262520 |
281 | Q>K | No |
ClinGen Ensembl |
|
|
CA415262483 rs1557187106 |
286 | T>I | No |
ClinGen TOPMed |
|
|
CA10561985 rs782790575 |
286 | T>S | No |
ClinGen ExAC gnomAD |
|
|
CA415262481 rs1557187102 |
287 | V>L | No |
ClinGen gnomAD |
|
|
rs782047097 CA10561984 |
295 | S>P | No |
ClinGen ExAC gnomAD |
|
|
CA415262427 rs1169433111 |
296 | P>L | No |
ClinGen TOPMed |
|
|
CA10561983 rs781964455 |
297 | Q>* | No |
ClinGen ExAC gnomAD |
|
|
CA10561982 rs782351883 |
299 | C>S | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs369393190 CA337298429 |
300 | P>S | No |
ClinGen ESP gnomAD |
|
|
rs369393190 CA415262407 |
300 | P>T | No |
ClinGen ESP gnomAD |
|
|
rs1423588442 CA415262386 |
303 | A>S | No |
ClinGen TOPMed |
No associated diseases with P49184
4 GO annotations of cellular component
| Name | Definition |
|---|---|
| endoplasmic reticulum | The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached). |
| extracellular region | The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite. |
| nucleus | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
| specific granule lumen | The volume enclosed by the membrane of a specific granule, a granule with a membranous, tubular internal structure, found primarily in mature neutrophil cells. Most are released into the extracellular fluid. Specific granules contain lactoferrin, lysozyme, vitamin B12 binding protein and elastase. |
3 GO annotations of molecular function
| Name | Definition |
|---|---|
| deoxyribonuclease activity | Catalysis of the hydrolysis of ester linkages within deoxyribonucleic acid. |
| deoxyribonuclease I activity | Catalysis of the endonucleolytic cleavage of DNA to 5'-phosphodinucleotide and 5'-phosphooligonucleotide end products. |
| DNA binding | Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid). |
3 GO annotations of biological process
| Name | Definition |
|---|---|
| DNA catabolic process | The cellular DNA metabolic process resulting in the breakdown of DNA, deoxyribonucleic acid, one of the two main types of nucleic acid, consisting of a long unbranched macromolecule formed from one or two strands of linked deoxyribonucleotides, the 3'-phosphate group of each constituent deoxyribonucleotide being joined in 3',5'-phosphodiester linkage to the 5'-hydroxyl group of the deoxyribose moiety of the next one. |
| DNA catabolic process, endonucleolytic | The chemical reactions and pathways resulting in the breakdown of DNA, involving the hydrolysis of internal 3',5'-phosphodiester bonds in one or two strands of deoxyribonucleotides. |
| DNA metabolic process | Any cellular metabolic process involving deoxyribonucleic acid. This is one of the two main types of nucleic acid, consisting of a long, unbranched macromolecule formed from one, or more commonly, two, strands of linked deoxyribonucleotides. |
No homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| No homologous proteins | ||||
| 10 | 20 | 30 | 40 | 50 | 60 |
| MHYPTALLFL | ILANGAQAFR | ICAFNAQRLT | LAKVAREQVM | DTLVRILARC | DIMVLQEVVD |
| 70 | 80 | 90 | 100 | 110 | 120 |
| SSGSAIPLLL | RELNRFDGSG | PYSTLSSPQL | GRSTYMETYV | YFYRSHKTQV | LSSYVYNDED |
| 130 | 140 | 150 | 160 | 170 | 180 |
| DVFAREPFVA | QFSLPSNVLP | SLVLVPLHTT | PKAVEKELNA | LYDVFLEVSQ | HWQSKDVILL |
| 190 | 200 | 210 | 220 | 230 | 240 |
| GDFNADCASL | TKKRLDKLEL | RTEPGFHWVI | ADGEDTTVRA | STHCTYDRVV | LHGERCRSLL |
| 250 | 260 | 270 | 280 | 290 | 300 |
| HTAAAFDFPT | SFQLTEEEAL | NISDHYPVEV | ELKLSQAHSV | QPLSLTVLLL | LSLLSPQLCP |
| AA |